skip to main content
Show Results with:

Results 1 - 10 of 142  for Everything in this catalogue

results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

New drug targets in metastatic melanoma

Homet, Blanca; Ribas, Antoni

The Journal of pathology. Volume 232:Issue 2 (2014); pp 134-141 -- John Wiley & Sons

Online access

2
Material Type:
Article
Add to My workspace

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Eroglu, Zeynep; Ribas, Antoni

Therapeutic advances in medical oncology. Volume 8:Number 1 (2016, January); pp 48-56 -- SAGE Publications

Online access

3
Material Type:
Article
Add to My workspace

SnapShot: Immune Checkpoint Inhibitors

Abril-Rodriguez, Gabriel; Ribas, Antoni

Cancer cell -- Volume: 31 6;848.e1) -- 2017

Online access

4
Material Type:
Article
Add to My workspace

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

Shin, Daniel Sanghoon; Ribas, Antoni

Current opinion in immunology. Volume 33 (2015, April); pp 23-35 -- Elsevier

Online access

5
Material Type:
Article
Add to My workspace

New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone

Hu-Lieskovan, Siwen; Ribas, Antoni

The cancer journal. Volume 23:Issue 1 (2017, January/February); pp 10-22 -- Lippincott, Williams & Wilkins

Online access

6
Material Type:
Article
Add to My workspace

New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone

Hu-Lieskovan, Siwen; Ribas, Antoni

The cancer journal. Volume 23:Issue 1 (2017) -- Lippincott, Williams & Wilkins

Online access

7
Material Type:
Article
Add to My workspace

What does PD-L1 positive or negative mean?

Ribas, Antoni; Hu-Lieskovan, Siwen

Journal of experimental medicine -- Rockefeller University -- Volume: 213 13; (pages 2835-2840) -- 2016

Check library holdings

8
Material Type:
Article
Add to My workspace

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

Shin, Daniel Sanghoon; Ribas, Antoni

Elsevier -- 2015

Online access

9
Material Type:
Article
Add to My workspace

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

Shin, Daniel Sanghoon; Ribas, Antoni

Current opinion in immunology. Volume 33 (2015, April); pp 23-35 -- Elsevier

Online access

10
Material Type:
Article
Add to My workspace

Gauging the Long-Term Benefits of Ipilimumab in Melanoma

Ribas, Antoni|Flaherty, Keith T.

journal of clinical oncology -- American Society of Clinical Oncology -- Volume: 33 Part: 17; (pages 1865-1866) -- 2015

Check library holdings

Results 1 - 10 of 142  for Everything in this catalogue

results 1 2 3 4 5 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (103)
  2. Online: Reading Room only  (92)
  3. Purchase a copy  (67)
  4. Refine further open sub menu

Material type 

  1. Articles  (139)
  2. Books  (3)
  3. Refine further open sub menu

Creation date 

From To
  1. Before2011  (3)
  2. 2011To2012  (3)
  3. 2013To2014  (13)
  4. 2015To2017  (92)
  5. After 2017  (31)
  6. Refine further open sub menu

Language 

  1. Catalan  (3)
  2. English  (1)
  3. Refine further open sub menu

Additional Features 

  1. Abstract  (109)
  2. No Abstract  (30)
  3. Refine further open sub menu

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. Ribas, Antoni
  2. Long, Georgina V
  3. Schadendorf, Dirk
  4. Robert, Caroline
  5. Flaherty, Keith T.

Searching Remote Databases, Please Wait